Webinars Overview
Advancements in drug design have resulted in resurging interest in drugs that form covalent bonds with their targets, often referred to as targeted covalent inhibitors. Covalent drugs have the potential to provide enhanced potency and prolonged duration of action compared to non-covalent drugs. However, it is critical for covalent inhibitors to exhibit sufficient selectivity to mitigate off-target effects caused by binding to unintended proteins.
In this webinar, our speaker will introduce the unique DMPK properties of covalent drugs to support lead optimization efforts.
Complete the form to view this webinar.
Stay Connected
Keep up with the latest news and insights.
